Status: current, Defined. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4536356012 | Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4536357015 | R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | en | Synonym | Active | Case sensitive | SNOMED CT core |
| 4536358013 | Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen (regime/therapy) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4536359017 | RCEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Is a | Rituximab therapy | true | Inferred relationship | Some | ||
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Is a | Corticosteroid and/or corticosteroid derivative therapy | true | Inferred relationship | Some | ||
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Is a | Antineoplastic chemotherapy regimen | true | Inferred relationship | Some | ||
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Is a | Cyclophosphamide therapy | true | Inferred relationship | Some | ||
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | Prednisone | true | Inferred relationship | Some | 1 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Method | Administration - action | true | Inferred relationship | Some | 1 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | Rituximab | true | Inferred relationship | Some | 2 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Method | Administration - action | true | Inferred relationship | Some | 2 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Method | Administration - action | true | Inferred relationship | Some | 3 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | Vincristine | true | Inferred relationship | Some | 3 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Method | Administration - action | true | Inferred relationship | Some | 4 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | Etoposide | true | Inferred relationship | Some | 4 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Method | Administration - action | true | Inferred relationship | Some | 5 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Direct substance | Cyclophosphamide | true | Inferred relationship | Some | 5 | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Has intent | Therapeutic | true | Inferred relationship | Some | 6 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Procedure foundation reference set
FHIR